Clot-buster proves safe, effective when given during first three hours after a stroke.
D000925:Anticoagulants / Q000009:adverse effects / Q000627:therapeutic use; D000075202:Contraindications; D006801:Humans; D020521:Stroke / Q000188:drug therapy*; D013997:Time Factors; D010959:Tissue Plasminogen Activator / Q000009:adverse effects / Q000627:therapeutic use; D016896:Treatment Outcome
D000925:Anticoagulants; D010959:Tissue Plasminogen Activator